Diabetes in Asians

Endocrinology and Metabolism

Volumn 30, Issue 3, 2015, Pages 263-269

  Rhee, Eun Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Asian; Diabetes mellitus; Type 2

Indexed keywords

EID: 84955489679     PISSN: 2093596X     EISSN: 20935978     Source Type: Journal    
DOI: 10.3803/EnM.2015.30.3.263     Document Type: Review

References (52)

1. International Diabetes Federation. IDF diabetes atlas, 6th ed [Internet]. Brussels: International Diabetes Federation; c2014 [cited 2015 Aug 18]. Available from: http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf.
2. Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013;1281:64-91.
3. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-8.
4. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011;35:303-8.
5. Weber MB, Oza-Frank R, Staimez LR, Ali MK, Narayan KM. Type 2 diabetes in Asians: prevalence, risk factors, and effectiveness of behavioral intervention at individual and population levels. Annu Rev Nutr 2012;32:417-39.
6. Gujral UP, Pradeepa R, Weber MB, Narayan KM, Mohan V. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63.
7. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010;375:408-18.
8. Ha KH, Kim DJ. Trends in the diabetes epidemic in Korea.Endocrinol Metab (Seoul) 2015;30:142-6.
9. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101.
10. Li H, Oldenburg B, Chamberlain C, O'Neil A, Xue B, Jolley D, et al. Diabetes prevalence and determinants in adults in China mainland from 2000 to 2010: a systematic review. Diabetes Res Clin Pract 2012;98:226-35.
11. Korean Diabetes Association. Diabetes fact sheet in Korea 2013 [Internet]. Seoul: Korean Diabetes Association; c2011 [cited 2015 Aug 18]. Available from: http://www.diabetes.or.kr/temp/diabetes_factsheet_2013111.pdf.
12. Jeon JY, Kim DJ, Ko SH, Kwon HS, Lim S, Choi SH, et al. Current status of glycemic control of patients with diabetes in Korea: the fifth Korea National Health and Nutrition Examination Survey. Diabetes Metab J 2014;38:197-203.
13. Ko KS, Oh TG, Kim CH, Park KS, Lee MK, Kim SY, et al. A clinical study on the complications of non-insulin-dependent diabetes mellitus in Korea. J Korean Diabetes Assoc 1991;15:257-62.
14. Korean Ministry of Health and Welfare. Korea health statistics 2012: Korea National Health and Nutrition Examination Survey. Seoul: Korean Ministry of Health and Welfare; 2014.
15. Cockram CS. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J 2000;6:43-52.
16. Popkin BM. The nutrition transition and its health implications in lower-income countries. Public Health Nutr 1998; 1:5-21.
17. Centers for Disease Control and Prevention (CDC); National Center for Health Statistics. National Health and Nutrition Examination Survey, 2013 [Internet]. Hyattsville: Centers for Disease Control and Prevention; 2014 [updated 2014 Feb 3; cited 2015 Apr 27]. Available from: http://www.cdc.gov.
18. Chan JC, So W, Ma RC, Tong PC, Wong R, Yang X. The complexity of vascular and non-vascular complications of diabetes: the Hong Kong Diabetes Registry. Curr Cardiovasc Risk Rep 2011;5:230-9.
19. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care 2011;34:1741-8.
20. Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol 2014;2:935-43.
21. Sellayah D, Cagampang FR, Cox RD. On the evolutionary origins of obesity: a new hypothesis. Endocrinology 2014;155: 1573-88.
22. Bar-Or O, Foreyt J, Bouchard C, Brownell KD, Dietz WH, Ravussin E, et al. Physical activity, genetic, and nutritional considerations in childhood weight management. Med Sci Sports Exerc 1998;30:2-10.
23. Kim C. Gestational diabetes mellitus in korean women: similarities and differences from other racial/ethnic groups. Diabetes Metab J 2014;38:1-12.
24. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998;22:1164-71.
25. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002;3: 141-6.
26. Wang J, Thornton JC, Burastero S, Shen J, Tanenbaum S, Heymsfield SB, et al. Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area. Obes Res 1996;4: 377-84.
27. Araneta MR, Wingard DL, Barrett-Connor E. Type 2 diabetes and metabolic syndrome in Filipina-American women: a high-risk nonobese population. Diabetes Care 2002;25:494-9.
28. Yajnik CS, Yudkin JS. The Y-Y paradox. Lancet 2004;363:163.
29. Deurenberg-Yap M, Li T, Tan WL, van Staveren WA, Deurenberg P. Validation of a semiquantitative food frequency questionnaire for estimation of intakes of energy, fats and cholesterol among Singaporeans. Asia Pac J Clin Nutr 2000; 9:282-8.
30. World Health Organization, International Obesity Task Force. The Asian-Pacific perspective: redefining obesity and its treatment. Geneva: WHO Western Pacific Region; 2000.
31. Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, et al. 2014 Clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul) 2014;29:405-9.
32. Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2010;1801:209-14.
33. Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract 2004;66 Suppl 1:S37-43.
34. Rattarasarn C, Soonthornpan S, Leelawattana R, Setasuban W. Decreased insulin secretion but not insulin sensitivity in normal glucose tolerant Thai subjects. Diabetes Care 2006;29:742-3.
35. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003;88:2300-8.
36. Taniguchi A, Fukushima M, Sakai M, Nagata I, Doi K, Nagasaka S, et al. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care 2000;23:127-8.
37. Cho YS, Chen CH, Hu C, Long J, Ong RT, Sim X, et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 2012;44:67-72.
38. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008;40:1092-7.
39. Popkin BM, Horton S, Kim S, Mahal A, Shuigao J. Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr Rev 2001;59:379-90.
40. Villegas R, Liu S, Gao YT, Yang G, Li H, Zheng W, et al. Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med 2007;167: 2310-6.
41. Nanri A, Mizoue T, Noda M, Takahashi Y, Kato M, Inoue M, et al. Rice intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr 2010;92:1468-77.
42. Henry CJ, Lightowler HJ, Newens K, Sudha V, Radhika G, Sathya RM, et al. Glycaemic index of common foods tested in the UK and India. Br J Nutr 2008;99:840-5.
43. Lee ET, Lu M, Bennett PH, Keen H. Vascular disease in younger-onset diabetes: comparison of European, Asian and American Indian cohorts of the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001;44 Suppl 2:S78-81.
44. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006;69:2057-63.
45. Clarke PM, Glasziou P, Patel A, Chalmers J, Woodward M, Harrap SB, et al. Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Med 2010;7:e1000236.
46. Liu J, Hong Y, D'Agostino RB Sr, Wu Z, Wang W, Sun J, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 2004;291:2591-9.
47. Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 2003;26:360-6.
48. Kim JH, Kim DJ, Jang HC, Choi SH. Epidemiology of micro-and macrovascular complications of type 2 diabetes in Korea. Diabetes Metab J 2011;35:571-7.
49. Weng J, Soegondo S, Schnell O, Sheu WH, Grzeszczak W, Watada H, et al. Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database. Diabetes Metab Res Rev 2015;31:155-67.
50. Pan CY, Landen H. Post-marketing surveillance of acarbose treatment in patients with type 2 diabetes mellitus and subjects with impaired glucose tolerance in China. Clin Drug Investig 2007;27:397-405.
51. Gamble JM, Clarke A, Myers KJ, Agnew MD, Hatch K, Snow MM, et al. Incretin-based medications for type 2 diabetes: an overview of reviews. Diabetes Obes Metab 2015;17: 649-58.
52. Kim YG, Hahn S, Oh TJ, Kwak SH, Park KS, Cho YM. Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis. Diabetologia 2013;56:696-708.